Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells

Journal of Ovarian Research

Volumn 3, Issue 1, 2010, Pages

  Rough, James J ^a   Monroy, M Alexandra ^a   Yerrum, Smitha ^a   Daly, John M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CYCLIN A; CYCLIN D; CYCLIN E; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PROTEIN BAX; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 77954067003     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-3-13     Document Type: Article

References (26)

1. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. BK Edwards HL Howe LA Ries MJ Thun HM Rosenberg R Yancik PA Wingo A Jemal EG Feigal, Cancer 2002 94 2766 92 10.1002/cncr.10593 12173348
2. Cancer statistics. A Jemal T Siegel E Ward Y Hao T Murray MJ Thun, CA Cancer J Clin 2008 55 10 30 10.3322/canjclin.55.1.10
3. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. BA Goff LS Mandel CH Melancon HG Muntz, JAMA 2004 22 2705 12 10.1001/jama.291.22.2705 (Pubitemid 38725419)
4. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer: Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. ME Van der Burg M van Lent M Buyse, N Engl J Med 1995 10 629 34 10.1056/NEJM199503093321002
5. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. R Apfel D Benbrook E Lernhardt MA Ortiz G Salbert M Pfahl, Mol Cell Biol 1994 14 7025 35 7935418
6. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. TT Lu JJ Repa DJ Mangelsdorf, J Biol Chem 2001 276 37735 8 11459853
7. LXR, a nuclear receptor that defines a distinct retinoid response pathway. PJ Willy K Umesono ES Ong RM Evans RA Heyman DJ Mangelsdorf, Genes Dev 1995 9 1033 45 10.1101/gad.9.9.1033 7744246
8. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. JM Lehmann SA Kliewer LB Moore TA Smith-Oliver BB Oliver JL Su SS Sundseth DA Winegar DE Blanchard TA Spencer TM Willson, J Biol Chem 1997 272 3137 40 10.1074/jbc.272.6.3137 9013544
9. Nuclear receptors and lipid physiology: opening the X-files. A Chawla JJ Repa RM Evans DJ Mangelsdorf, Science 2001 294 1866 70 10.1126/science.294.5548. 1866 11729302
10. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. A Castrillo P Tontonoz, Annu Rev Cell Dev Biol 2004 20 455 80 10.1146/annurev.cellbio.20.012103.134432 15473848
11. The liver X receptor agonist T0901317 acts as androgen receptor antagonist in human prostate cancer cells. CP Chuu RY Chen RA Hiipakka JM Kokontis KV Warner J Xiang S Liao, Biochem Biophys Res Commun 2007 57 341 6 10.1016/j.bbrc.2007.03.116 (Pubitemid 46603137)
12. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. CP Chuu RA Hiipakka JM Kokontis J Fukuchi RY Chen S Liao, Cancer Res 2006 66 6482 6 10.1158/0008-5472.CAN-06-0632 16818617
13. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. J Fukuchi JM Kokontis RA Hiipakka CP Chuu S Liao, Cancer Res 2004 64 7686 9 10.1158/0008-5472.CAN-04-2332 15520170
14. The nuclear oxysterol receptor LXRalpha is expressed in the normal human breast and in breast cancer. DM Vigushin Y Dong L Inman N Peyvandi JP Alao C Sun S Ali EJ Niesor CL Bentzen RC Coombes, Med Oncol 2004 21 123 31 10.1385/MO:21:2:123 15299184
15. Activation of liver X receptors and retinoid X receptors induces growth arrest and apoptosis in insulin-secreting cells. W Wente MB Brenner H Zitzer J Gromada AM Efanov, Endocrinology 2007 148 1843 9 10.1210/en.2006-1247 17194744
16. Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. J Pfisterer M Plante I Vergote A du Bois H Hirte AJ Lacave, J Clin Onco 2006 29 4699 707 10.1200/JCO.2006.06.0913 (Pubitemid 46630933)
17. Liver X receptors as integrators of metabolic and inflammatory signaling. N Zelcer P Tontonoz, J Clin Invest 2006 116 607 14 10.1172/JCI27883 16511593
18. Novel Role for the liver X nuclear receptor in suppression of lung inflammatory responses. M Birrell M Catley E Hardaker S Wong T Willson K McCluskie T Leonard S Farrow J Collins S Haj-Yahai M Belvisi, J Biol Chem 2007 44 31822 90
19. T0901317 is a potent PXR ligand: Implications for the biology ascribed to LXR. N Mitro L Vargas R Romeo A Koder E Saez, FEBS Letters 2007 9 1721 1726 10.1016/j.febslet.2007.03.047 (Pubitemid 46602262)
20. T0901317 is a dual LXR/FXR agonist. KA Houck KM Borchert CD Hepler JS Thomas KS Bramlett LF Michael TP Burris, Molecular Genetics and Metabolism 2004 83 184 187 10.1016/j.ymgme.2004.07.007 15464433
21. Phase I Pharmacokinetic Trial and Correlative in Vitro Phase II Tumor Kinetic Study of Apomine (SR-45023 A), a Novel Oral Biphosphonate Anticancer Drug. DS Alberts AV Hallum III M Stratton-Custis DJ Garcia M Gleason-Guzman SE Salmon P Santabarbara EJ Niesor S Floret CL Bentzen, Clinical Cancer Research 2001 7 1246 1250 11350890
22. The Farsenoid X Receptor Is Expressed in Breast Cancer and Regulates Apoptosis and Aromatase Expression. KE Swales M Korbonits R Carpenter DT Walsh TD Warner D Bishop-Bailey, Cancer Research 2006 20 10120 10126 10.1158/0008-5472.CAN-06-2399 (Pubitemid 44672066)
23. A Sharper Image of SHP. K Choonjans J Auwerx, Nature 2002 8 789 791 10.1038/nm0802-789
24. CDK inhibitors: positive and negative regulators of G1-phase progression. CJ Sherr JM Roberts, Genes Dev 1999 13 1501 12 10.1101/gad.13.12.1501 10385618
25. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. L Connell-Crowley JW Harper DW Goodrich, Mol Biol Cell 1997 8 287 301 9190208
26. Effects of diallyl disulfide (DADS) on expression of apoptosis associated proteins in androgen independent human prostate cancer cells (PC-3). R Gayathri DN Gunadharini A Arunkumar K Senthilkumar G Krishnamoorthy S Banudevi RC Vignesh J Arunakaran, Mol Cell Biochem 2009 320 197 203 10.1007/s11010-008-9903- 5 18759062